Showing results (391-400 of 411) with videos related to
Sort By:
Pageof 42
Nature Communications|February 5, 2025
Spatially mapping the tumour immune microenvironments of non-small cell lung cancerLysanne Desharnais, Mark Sorin, Morteza Rezanejad, et al.Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|September 9, 2017
Perforated esophageal intervention focus (PERF) study: a multi-center examination of contemporary treatmentJ T Ali, R D Rice, E A David, et al.The Annals of Thoracic Surgery|November 7, 2025
Clinical Characteristics and Surgical Outcomes of Patients Receiving Perioperative Pembrolizumab in KEYNOTE-671Moishe Liberman, David R Jones, Heather Wakelee, et al.Journal for Immunotherapy of Cancer|February 1, 2023
Single-cell spatial landscape of immunotherapy response reveals mechanisms of CXCL13 enhanced antitumor immunityMark Sorin, Elham Karimi, Morteza Rezanejad, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|March 24, 2026
A subgroup analysis of perioperative pembrolizumab in clinical stage II non-small-cell lung cancer from the randomized keynote-671 studyMasahiro Tsuboi, Heather Wakelee, Marina C Garassino, et al.Lancet (London, England)|September 17, 2024
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trialJonathan D Spicer, Marina C Garassino, Heather Wakelee, et al.Cancer Immunology, Immunotherapy : CII|February 26, 2022
Murine fecal microbiota transfer models selectively colonize human microbes and reveal transcriptional programs associated with response to neoadjuvant checkpoint inhibitorsFyza Y Shaikh, Joell J Gills, Fuad Mohammad, et al.Clinical Lung Cancer|February 20, 2024
Transitioning to Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: Trends and Surgical Outcomes in a Regionalized Pulmonary Oncology NetworkYohann Pilon, Merav Rokah, Joseph Seitlinger, et al.The Annals of Thoracic Surgery|October 30, 2025
Neoadjuvant Chemotherapy-Immunotherapy in Non-Small Cell Lung Cancer: Can Positron Emission Tomography Scan Predict Complete Pathologic Response?Joseph Seitlinger, Olivier Salko, Luciano Bulgarelli Maqueda, et al.The Journal of Experimental Medicine|April 18, 2020
Targeting potential drivers of COVID-19: Neutrophil extracellular trapsBetsy J Barnes, Jose M Adrover, Amelia Baxter-Stoltzfus, et al.Pageof 42